World STDs Diagnosis Market Size Estimated to Reach $141.4 Billion by 2026

World STDs Diagnosis Market size is estimated to reach $141.4 billion by 2026, growing at a CAGR of 5.6% during the forecast period 2021-2026. Sexually transmitted diseases (STDs) are infections that spread from one person to another through sexual contact. These infections are caused by bacteria, viruses, and parasites. Sexually transmitted infections are an important global health priority concern owing to their devastating impact on women and infants. Infection with certain STDs also increases the risk of getting and transmitting human immunodeficiency viruses as well as alters the way the disease progresses. Rise in the prevalence of sexually transmitted infections caused by human immunodeficiency viruses and trichomonas vaginalis, growing awareness about the advantages provided by the point of care (PoC) testing devices, and increase in the implementation of national screening programs are the factors that are set to drive the growth of the World STDs Diagnosis Market for the period 2021-2026. Key Takeaways Geographically, North America World STDs Diagnosis Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing prevalence of sexually transmitted infections caused by human immunodeficiency viruses. The rise in the demand for advanced testing devices for the treatment of chlamydia is driving the Chlamydia Testing segment. However, limited access to sexually transmitted infections diagnosis in developing nations is one of the major factors that is said to reduce the growth of the World STDs Diagnosis Market. Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the World STDs Diagnosis Market report. World STDs Diagnosis Market Segment Analysis-By Type The World STDs Diagnosis Market based on the Type can be further segmented into Gonorrhea Testing, Chlamydia Testing, Human Papilloma Virus (HPV) Testing, Chancroid Testing, P&S Syphilis Testing, and Human Immunodeficiency Virus (HIV) Testing. The Chlamydia Testing segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 6.7% over the period 2021-2026. This growth is owing to the factors such as growing awareness about the complications related to the disease and increasing demand for advanced testing devices for the treatment of chlamydia. The rise in the adoption of diagnostic tests that are efficient in providing rapid results with high sensitivity for the treatment of chlamydia is driving the growth of the World STDs Diagnosis Market. The P&S Syphilis Testing segment held the second largest share in 2020 owing to the factors such as the growing prevalence of syphilis infections among bisexuals and increase in the incidence of weakened immune systems coupled with unprotected sex in developed nations. World STDs Diagnosis Market Segment Analysis-By Location The World STDs Diagnosis Market based on the Location can be further segmented into Laboratory Testing and Point Of Care (PoC) Testing. The Laboratory Testing segment held the largest share in 2020 owing to the factors such as growing demand for advanced laboratory testing devices and rise in the investment by the key players for expanding the services for the treatment of sexually transmitted infections. The rise in the demand for laboratory testing for the treatment of sexually transmitted infections caused by human immunodeficiency viruses and trichomonas vaginalis is driving the growth of the World STDs Diagnosis Market. The Point Of Care (PoC) Testing segment is estimated to be the fastest growing segment with a CAGR of 6.2% over the period 2021-2026. This growth is owing to the factors such as growing awareness about the advantages provided by the point of care (PoC) testing devices and increase in the inclination towards faster diagnosis in developed nations. World STDs Diagnosis Market Segment Analysis-By Geography North America held the largest share with 28% of the overall market in 2020. The growth in this segment is owing to the factors such as the growing prevalence of syphilis infections among bisexuals and increase in the demand for faster diagnosis in developed nations. The rise in the prevalence of sexually transmitted infections caused by human immunodeficiency viruses is driving the growth of the World STDs Diagnosis Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing awareness about the advantages provided by the point of care (PoC) testing devices and rise in the prevalence of sexually transmitted infections caused by trichomonas vaginalis. World STDs Diagnosis Market Drivers Increase in the Implementation of National Screening Programs With the increase in the prevalence of various sexually transmitted infections caused by human immunodeficiency viruses and trichomonas vaginalis, several countries across the globe are focusing on implementing national screening programs to expand the coverage of sexually transmitted infections diagnosis. Moreover, favorable reimbursement policies have also been implemented, which is propelling the growth of the World STDs Diagnosis Market. Rise in the Prevalence of Gonorrhea Gonorrhea is one of the most common bacterial sexually transmitted infections that results in substantial morbidity and economic cost worldwide. It can be easily passed between people through unprotected vaginal and anal sex. However, it is easily diagnosed by testing a sample of discharge, which is picked up using a swab. The rising burden of gonorrhea across the world is one of the major factors driving the growth of the World STDs Diagnosis Market. World STDs Diagnosis Market Challenges Limited Access to Sexually Transmitted Infections Diagnosis in Developing Nations The governments of developed nations are focusing on the betterment of healthcare infrastructure and the introduction of advanced diagnostics infrastructure to provide precise testing results facilitating better treatment for sexually transmitted infections. However, limited access to sexually transmitted infections diagnosis in developing nations is one of the major factors that is estimated to reduce the growth of the World STDs Diagnosis Market. World STDs Diagnosis Market Competitive Landscape: Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the World STDs Diagnosis Market. Key companies of this market are Becton Dickinson and Company, Roche Holdings AG, Alere Inc, BioMerieux, Danaher Corporation, Abbott Laboratories, DiaSorin, Orasure, Quest Diagnostics, and Hologic Inc among others. Partnerships/Product Launches: